Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Loss of CD103+ intestinal dendritic cells during colonic inflammation.

Strauch UG, Grunwald N, Obermeier F, Gürster S, Rath HC.

World J Gastroenterol. 2010 Jan 7;16(1):21-9.

2.

Calcitriol analog ZK191784 ameliorates acute and chronic dextran sodium sulfate-induced colitis by modulation of intestinal dendritic cell numbers and phenotype.

Strauch UG, Obermeier F, Grunwald N, Dunger N, Rath HC, Schölmerich J, Steinmeyer A, Zügel U, Herfarth HH.

World J Gastroenterol. 2007 Dec 28;13(48):6529-37.

3.

Self-expanding Polyflex plastic stents in esophageal disease: various indications, complications, and outcomes.

Ott C, Ratiu N, Endlicher E, Rath HC, Gelbmann CM, Schölmerich J, Kullmann F.

Surg Endosc. 2007 Jun;21(6):889-96.

PMID:
17177084
4.

Acceptance of flexible sigmoidoscopy as a screening examination for colorectal cancer in an outpatient clinic.

Gölder S, Vogt W, Lichti H, Rath HC, Kullmann A, Schölmerich J, Kullmann F.

Int J Colorectal Dis. 2007 Apr;22(4):387-94. Epub 2006 Jul 4.

PMID:
16819639
5.

PCR/DGGE and 16S rRNA gene library analysis of the colonic microbiota of HLA-B27/beta2-microglobulin transgenic rats.

McBurney W, Mangold M, Munro K, Schultz M, Rath HC, Tannock GW.

Lett Appl Microbiol. 2006 Feb;42(2):165-71.

6.

The effect of chromoendoscopy on the diagnostic improvement of gastric ulcers by endoscopists with different levels of experience.

Raţiu N, Rath HC, Büttner R, Gelbmann C, Klebl F, Kullmann F, Rogler G, Strauch UG, Schölmerich J, Messmann H.

Rom J Gastroenterol. 2005 Sep;14(3):239-44.

7.

Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.

Strauch UG, Obermeier F, Grunwald N, Gürster S, Dunger N, Schultz M, Griese DP, Mähler M, Schölmerich J, Rath HC.

Gut. 2005 Nov;54(11):1546-52. Epub 2005 Jun 29.

8.

In vivo CpG DNA/toll-like receptor 9 interaction induces regulatory properties in CD4+CD62L+ T cells which prevent intestinal inflammation in the SCID transfer model of colitis.

Obermeier F, Strauch UG, Dunger N, Grunwald N, Rath HC, Herfarth H, Schölmerich J, Falk W.

Gut. 2005 Oct;54(10):1428-36. Epub 2005 May 5.

9.

Green fluorescent protein for detection of the probiotic microorganism Escherichia coli strain Nissle 1917 (EcN) in vivo.

Schultz M, Watzl S, Oelschlaeger TA, Rath HC, Göttl C, Lehn N, Schölmerich J, Linde HJ.

J Microbiol Methods. 2005 Jun;61(3):389-98.

PMID:
15767015
10.
11.

Use of self-expandable plastic stents for the treatment of esophageal perforations and symptomatic anastomotic leaks.

Gelbmann CM, Ratiu NL, Rath HC, Rogler G, Lock G, Schölmerich J, Kullmann F.

Endoscopy. 2004 Aug;36(8):695-9.

PMID:
15280974
12.

Comparison of interobserver agreement for different scoring systems for reflux esophagitis: Impact of level of experience.

Rath HC, Timmer A, Kunkel C, Endlicher E, Grossmann J, Hellerbrand C, Herfarth HH, Lock G, Sahrbacher U, Schölmerich J, Kullmann F, Messmann H.

Gastrointest Endosc. 2004 Jul;60(1):44-9.

PMID:
15229424
13.

Effects of feeding a probiotic preparation (SIM) containing inulin on the severity of colitis and on the composition of the intestinal microflora in HLA-B27 transgenic rats.

Schultz M, Munro K, Tannock GW, Melchner I, Göttl C, Schwietz H, Schölmerich J, Rath HC.

Clin Diagn Lab Immunol. 2004 May;11(3):581-7.

14.

Lactobacillus GG in inducing and maintaining remission of Crohn's disease.

Schultz M, Timmer A, Herfarth HH, Sartor RB, Vanderhoof JA, Rath HC.

BMC Gastroenterol. 2004 Mar 15;4:5.

15.

Detection of dysplastic lesions by fluorescence in a model of chronic colitis in rats after local application of 5-aminolevulinic acid and its esterified derivatives.

Endlicher E, Rümmele P, Hausmann F, Rath HC, Knüchel R, Krieg RC, Schölmerich J, Messmann H.

Photochem Photobiol. 2004 Feb;79(2):189-92.

PMID:
15068031
16.

Preventive effects of Escherichia coli strain Nissle 1917 on acute and chronic intestinal inflammation in two different murine models of colitis.

Schultz M, Strauch UG, Linde HJ, Watzl S, Obermeier F, Göttl C, Dunger N, Grunwald N, Schölmerich J, Rath HC.

Clin Diagn Lab Immunol. 2004 Mar;11(2):372-8.

17.

Functional expression of the interleukin-11 receptor alpha-chain and evidence of antiapoptotic effects in human colonic epithelial cells.

Kiessling S, Muller-Newen G, Leeb SN, Hausmann M, Rath HC, Strater J, Spottl T, Schlottmann K, Grossmann J, Montero-Julian FA, Scholmerich J, Andus T, Buschauer A, Heinrich PC, Rogler G.

J Biol Chem. 2004 Mar 12;279(11):10304-15. Epub 2003 Dec 29.

18.

Rationale for probiotic and antibiotic treatment strategies in inflammatory bowel diseases.

Schultz M, Schölmerich J, Rath HC.

Dig Dis. 2003;21(2):105-28. Review.

PMID:
14571109
19.

The role of endogenous bacterial flora: bystander or the necessary prerequisite?

Rath HC.

Eur J Gastroenterol Hepatol. 2003 Jun;15(6):615-20. Review.

PMID:
12840671
20.

Gastrointestinal disorders of the critically ill. Bacterial translocation in the gut.

Wiest R, Rath HC.

Best Pract Res Clin Gastroenterol. 2003 Jun;17(3):397-425. Review.

PMID:
12763504
21.

[Complicated ulcerative colitis].

Rath HC, Folwaczny C.

Z Gastroenterol. 2003 Mar;41 Suppl 1:S23-8. German. No abstract available.

PMID:
12664337
22.
23.

[Extraintestinal manifestations in chronic inflammatory bowel diseases].

Rath HC, Herfarth HH.

Versicherungsmedizin. 2002 Mar 1;54(1):16-20. German.

PMID:
11933861
24.

Protoporphyrin IX distribution following local application of 5-aminolevulinic acid and its esterified derivatives in the tissue layers of the normal rat colon.

Endlicher E, Rümmele P, Hausmann F, Krieg R, Knüchel R, Rath HC, Schölmerich J, Messmann H.

Br J Cancer. 2001 Nov 16;85(10):1572-6.

25.

Different subsets of enteric bacteria induce and perpetuate experimental colitis in rats and mice.

Rath HC, Schultz M, Freitag R, Dieleman LA, Li F, Linde HJ, Schölmerich J, Sartor RB.

Infect Immun. 2001 Apr;69(4):2277-85.

26.

Nuclear factor-kappa B activity and intestinal inflammation in dextran sulphate sodium (DSS)-induced colitis in mice is suppressed by gliotoxin.

Herfarth H, Brand K, Rath HC, Rogler G, Schölmerich J, Falk W.

Clin Exp Immunol. 2000 Apr;120(1):59-65.

28.

Varying cecal bacterial loads influences colitis and gastritis in HLA-B27 transgenic rats.

Rath HC, Ikeda JS, Linde HJ, Schölmerich J, Wilson KH, Sartor RB.

Gastroenterology. 1999 Feb;116(2):310-9.

PMID:
9922311
29.

[Initial symptoms, extra-intestinal manifestations and course of pregnancy in chronic inflammatory bowel diseases].

Rath HC, Andus T, Caesar I, Schölmerich J.

Med Klin (Munich). 1998 Jul 15;93(7):395-400. German.

PMID:
9711052
30.

[Nutritional deficiencies and complications in chronic inflammatory bowel diseases].

Rath HC, Caesar I, Roth M, Schölmerich J.

Med Klin (Munich). 1998 Jan 15;93(1):6-10. German.

PMID:
9505072
31.

[Acute hemolytic crisis as the initial manifestation of Wilson disease].

Rath HC, Enger IM, Rüschoff J, Schölmerich J, Holstege A.

Z Gastroenterol. 1997 Mar;35(3):199-203. German.

PMID:
9173689
32.

Interleukin 10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers.

Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S, Sartor RB.

Gut. 1996 Dec;39(6):836-45.

33.

Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human beta2 microglobulin transgenic rats.

Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm TE Jr, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB.

J Clin Invest. 1996 Aug 15;98(4):945-53.

34.

Selective plasma kallikrein inhibitor attenuates acute intestinal inflammation in Lewis rat.

Stadnicki A, DeLa Cadena RA, Sartor RB, Bender D, Kettner CA, Rath HC, Adam A, Colman RW.

Dig Dis Sci. 1996 May;41(5):912-20.

PMID:
8625762
35.

Animal models of intestinal and joint inflammation.

Sartor RB, Rath HC, Lichtman SN, van Tol EA.

Baillieres Clin Rheumatol. 1996 Feb;10(1):55-76. Review.

PMID:
8674149

Supplemental Content

Support Center